412
Views
0
CrossRef citations to date
0
Altmetric
Priority Paper Evaluation

Approach towards optimal physiological T-cell-mediated immune response

&
Pages 477-479 | Published online: 16 Jul 2010
 

Abstract

Evaluation of: Kirak O, Frickel EV, Grotenbreg GM et al.: Transnuclear mice with predefined T cell receptor specificities against Toxoplasma gondii obtained via SCNT. Science 238, 243–248 (2010). Transgenic mice with defined T-cell receptor (TCR) specificity are useful for studying the involvement of T-cell-mediated immune responses to antigenic epitopes. However, these transgenic mice were not easily established. Their creation is time consuming due to several hindrances such as random integration of the α- and β-chains of the transgenic TCR and the presence of exogenous promoter, among others. These drawbacks explain why only a few TCR transgenic mice are available so far. Somatic cell nuclear transfer represents another means to generate mice with defined TCR specificity. Kirak et al. described an experimental model based on somatic cell nuclear transfer that allowed them to obtain mice harboring TCR specific to Toxoplasma gondii. The apparent ease in establishing this experimental model could lead to the generation of mice with defined T-cell immune responses against other antigens in the near future.

Financial & competing interests disclosure

The financial support of this work is provided by Institut National de la Santé et de la Recherche Médicale (INSERM) U-1014, Regulation de la Survie Cellulaire et des Allogreffes, Université Paris XI, Groupe Hospitaler Paul-Brousse, 94800 Villejuif, France. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

The financial support of this work is provided by Institut National de la Santé et de la Recherche Médicale (INSERM) U-1014, Regulation de la Survie Cellulaire et des Allogreffes, Université Paris XI, Groupe Hospitaler Paul-Brousse, 94800 Villejuif, France. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.